• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情对加拿大和美国大麻使用情况的自我报告影响

Self-reported Impact of the COVID-19 Pandemic on Cannabis Use in Canada and the United States.

作者信息

Wadsworth Elle, Goodman Samantha, Hammond David

机构信息

School of Public Health Sciences, University of Waterloo, Waterloo, ON, Canada.

Canadian Centre on Substance Use and Addiction, Ottawa, ON, Canada.

出版信息

J Psychoactive Drugs. 2023 Sep-Oct;55(4):483-492. doi: 10.1080/02791072.2022.2110023. Epub 2022 Aug 18.

DOI:10.1080/02791072.2022.2110023
PMID:35981105
Abstract

The current study examined the self-reported impact of the COVID-19 pandemic on cannabis consumption and behaviors among past 12-month cannabis consumers in Canada and the U.S. across different cannabis laws. Cross-sectional survey data were collected in 2020 from respondents recruited through online commercial panels, aged 16-65, who consumed cannabis in the past 12 months (n = 13,689). Weighted multinomial logistic regression models examined differences between jurisdictions for five outcomes: 1) cannabis consumption; 2) use of product types; 3) use of sources to obtain cannabis; 4) legality of source used; and 5) access to cannabis. Approximately one third of cannabis consumers reported changes to their consumption during the pandemic. Edibles (23% - 31%) and dried flower (21% - 30%) were the two most common products that respondents reported they were "more likely" to use during the pandemic. Most consumers reported "no difference" to changes in sourcing cannabis. Compared to consumers in U.S. recreational states, consumers in U.S. medical (AOR = 1.27, 95% CI: 1.07, 1.50) and illegal states (AOR = 1.22, CI: 1.00,1.48) had higher odds of reporting it was "harder" to access cannabis, and consumers in Canada had lower odds (AOR = 0.73, CI: 0.63,0.84). Future research should examine whether these changes remain after public health restrictions due to the pandemic are removed.

摘要

当前的研究调查了新冠疫情对加拿大和美国过去12个月内吸食大麻的人群在不同大麻法律下的大麻消费及行为的自我报告影响。2020年通过在线商业面板招募了年龄在16 - 65岁之间、过去12个月内吸食过大麻的受访者(n = 13689),收集了横断面调查数据。加权多项逻辑回归模型研究了五个结果在不同司法管辖区之间的差异:1)大麻消费;2)产品类型的使用;3)获取大麻的来源使用;4)所使用来源的合法性;5)获取大麻的难易程度。大约三分之一的大麻消费者报告在疫情期间其消费发生了变化。食用大麻制品(23% - 31%)和干花(21% - 30%)是受访者报告在疫情期间“更有可能”使用的两种最常见产品。大多数消费者报告在获取大麻的来源方面“没有变化”。与美国娱乐用大麻合法化州的消费者相比,美国医用大麻合法化州(调整后比值比[AOR] = 1.27,95%置信区间[CI]:1.07,1.50)和非法州(AOR = 1.22,CI:1.00,1.48)的消费者报告获取大麻“更难”的几率更高,而加拿大的消费者几率更低(AOR = 0.73,CI:0.63,0.84)。未来的研究应考察在因疫情实施的公共卫生限制措施解除后,这些变化是否仍然存在。

相似文献

1
Self-reported Impact of the COVID-19 Pandemic on Cannabis Use in Canada and the United States.新冠疫情对加拿大和美国大麻使用情况的自我报告影响
J Psychoactive Drugs. 2023 Sep-Oct;55(4):483-492. doi: 10.1080/02791072.2022.2110023. Epub 2022 Aug 18.
2
Trends in the use of cannabis products in Canada and the USA, 2018 - 2020: Findings from the International Cannabis Policy Study.2018-2020 年加拿大和美国大麻制品使用趋势:国际大麻政策研究结果。
Int J Drug Policy. 2022 Jul;105:103716. doi: 10.1016/j.drugpo.2022.103716. Epub 2022 May 23.
3
Cannabis flower prices and transitions to legal sources after legalization in Canada, 2019-2020.2019-2020 年加拿大大麻合法化后大麻花价格和向合法来源的转变。
Drug Alcohol Depend. 2022 Feb 1;231:109262. doi: 10.1016/j.drugalcdep.2021.109262. Epub 2021 Dec 31.
4
Prices and Purchase Sources for Dried Cannabis Flower in the United States, 2019-2020.2019-2020 年美国干大麻花的价格和采购来源。
Cannabis Cannabinoid Res. 2023 Oct;8(5):923-932. doi: 10.1089/can.2021.0232. Epub 2022 Apr 1.
5
Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States.加拿大和美国娱乐用大麻的法律地位以及大麻替代阿片类药物或处方止痛药的自我报告情况。
Subst Abus. 2022;43(1):943-948. doi: 10.1080/08897077.2022.2060431.
6
Legal sourcing of ten cannabis products in the Canadian cannabis market, 2019-2021: a repeat cross-sectional study.2019-2021 年加拿大大麻市场十种大麻产品的合法来源:一项重复横断面研究。
Harm Reduct J. 2023 Feb 17;20(1):19. doi: 10.1186/s12954-023-00753-6.
7
Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets.合法与非法娱乐用大麻市场中大麻使用的流行情况及形式。
Int J Drug Policy. 2020 Feb;76:102658. doi: 10.1016/j.drugpo.2019.102658. Epub 2020 Jan 9.
8
Retail availability and legal purchases of dried flower in Canada post-legalization.加拿大合法化后干花的零售供应和合法购买情况。
Drug Alcohol Depend. 2021 Aug 1;225:108794. doi: 10.1016/j.drugalcdep.2021.108794. Epub 2021 May 29.
9
Self-reported THC content and associations with perceptions of feeling high among cannabis consumers.自我报告的四氢大麻酚含量与大麻使用者感知兴奋的关联。
Drug Alcohol Rev. 2023 Jul;42(5):1142-1152. doi: 10.1111/dar.13664. Epub 2023 Apr 16.
10
Adverse outcomes of cannabis use in Canada, before and after legalisation of non-medical cannabis: cross-sectional analysis of the International Cannabis Policy Study.加拿大在非医用大麻合法化前后使用大麻的不良后果:国际大麻政策研究的横断面分析。
BMJ Open. 2024 Jan 3;14(1):e077908. doi: 10.1136/bmjopen-2023-077908.

引用本文的文献

1
Cannabis Consumption Among Adults Aged 55-65 in Canada, 2018-2021.2018 - 2021年加拿大55 - 65岁成年人的大麻消费情况
J Drug Issues. 2025 Jan;55(1):33-49. doi: 10.1177/00220426231190022. Epub 2023 Jul 19.
2
Post-legalization shifts in cannabis use among young adults in Georgia-A nationally representative study.佐治亚州年轻人在大麻合法化后的使用变化——一项全国代表性研究
Addiction. 2025 Feb;120(2):335-346. doi: 10.1111/add.16688. Epub 2024 Oct 17.
3
Adverse outcomes of cannabis use in Canada, before and after legalisation of non-medical cannabis: cross-sectional analysis of the International Cannabis Policy Study.
加拿大在非医用大麻合法化前后使用大麻的不良后果:国际大麻政策研究的横断面分析。
BMJ Open. 2024 Jan 3;14(1):e077908. doi: 10.1136/bmjopen-2023-077908.